Whatever the ultimate mechanism(s) involved in maintaining a relatively high constitutive reactive oxygen set point, the possibility that some human colon cancers are oxidant-dependent provides a novel perspective from which to develop strategies against this disease, focusing on NOX1 as a therapeutic target. The gene discussed is NOX1; the disease is malignant colon neoplasm.